Stavroulakis Konstantinos, Argyriou Angeliki, Watts Mike, Varghese Joji J, Estes Bailey A, Torsello Giovanni, Bisdas Theodosios, Huasen Bella
Department of Vascular Surgery, St. Franziskus Hospital GmbH, Münster, Germany -
Department of Vascular Surgery, St. Franziskus Hospital GmbH, Münster, Germany.
J Cardiovasc Surg (Torino). 2019 Oct;60(5):572-581. doi: 10.23736/S0021-9509.19.11038-5. Epub 2019 Jun 21.
Despite the continuous evolution of endovascular therapy, severe calcification remains a major issue for the minimally invasive treatment of superficial femoral artery (SFA) disease. The presence of calcium might negatively affect both the crossing of peripheral lesions and outcomes of all available treatment modalities and is therefore associated with unfavorable acute and long-term results. This manuscript summarizes the challenges raised from severe calcified atherosclerotic lesions and presents the outcomes of the various endovascular modalities in the treatment of calcified SFA disease.
尽管血管内治疗不断发展，但严重钙化仍然是股浅动脉（SFA）疾病微创治疗的一个主要问题。钙的存在可能会对周围病变的通过以及所有可用治疗方式的结果产生负面影响，因此与不良的急性和长期结果相关。本文总结了严重钙化动脉粥样硬化病变带来的挑战，并介绍了各种血管内治疗方式在治疗钙化SFA疾病中的结果。
